AC

Active Biotech AB publSTO Active Biotech Stock Report

Last reporting period 31 Dec, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.013

Micro

Exchange

XSTO - Nasdaq STOCKHOLM AB

ACTI.ST Stock Analysis

AC

Uncovered

Active Biotech AB publ is uncovered by Eyestock quantitative analysis.

Market cap $B

0.013

Dividend yield

Shares outstanding

264.89 B

Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

View Section: Eyestock Rating